Next-Generation Contraceptives Market
完整報告名稱與涵蓋範圍
Next-Generation Contraceptives Market Size, Share & Trends Analysis Distribution by Gender (Male, Female), End User (Hospital Pharmacies, Retail Pharmacies, Online Channels), Offering (Drugs, Devices), and Segment Forecasts, 2024-2031
報告摘要
Across the 2024 to 2031 projection horizon, the worldwide Next-Generation Contraceptives Market is projected to register a CAGR of 8.2%.
Next-Generation Contraceptives covers reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next-Generation Contraceptives Market Snapshot
Chapter 4. Global Next-Generation Contraceptives Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Gender Estimates & Trend Analysis
5.1. by Gender & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Gender:
5.2.1. Male
5.2.2. Female
Chapter 6. Market Segmentation 2: by End User Estimates & Trend Analysis
6.1. by End User & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Channels
6.2.4. Others
Chapter 7. Market Segmentation 3: by Offering Estimates & Trend Analysis
7.1. by Offering & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Offering:
7.2.1. Drugs
7.2.2. Devices
Chapter 8. Next-Generation Contraceptives Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.1.2. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.1.3. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.1.4. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.2.2. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.2.3. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.2.4. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.3.2. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.3.3. Asia-Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.3.4. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.4.2. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.4.3. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.4.4. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.5.2. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.5.3. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.5.4. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie
9.2.2. Bayer Corporation
9.2.3. Cooper Surgical, Inc.
9.2.4. Church & Dwight Co, Inc.
9.2.5. Merck & Co Inc.
9.2.6. Pfizer
9.2.7. Reckitt Benckiser Group Plc
9.2.8. Teva Pharmaceuticals Industries Ltd.
9.2.9. The Female Health Company/Veru Inc.
9.2.10. Afaxys, Inc
9.2.11. Aditxt
9.2.12. Daré Bioscience, Inc
9.2.13. TherapeuticsMD, Inc
9.2.14. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們